Ulti_1170x120_5-11-20

Perrigo

Perrigo finalizes sale of vitamins business to IVC

Perrigo finalizes sale of vitamins business to IVC

DUBLIN, Ireland — Perrigo Co. plc has wrapped up the sale of its U.S. vitamins, minerals and supplements (VMS) business to International Vitamin Corp. (IVC). The cash deal, terms of which weren’t disclosed, was announced in late June. The VMS business was part of the Perrigo Nutritionals division, whose core products are store-brand infant formula

Perrigo releases store-brand version of Zegerid OTC

Perrigo releases store-brand version of Zegerid OTC

DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for omeprazole and sodium bicarbonate capsules 20 mg/1100 mg, an over-the-counter medicine for heartburn. Perrigo said Monday that its product marks the first store-brand launch of an equivalent to Bayer’s Zegerid OTC capsules. Shipments to retail customers are under way,

Perrigo to sell VMS business to IVC

Perrigo to sell VMS business to IVC

DUBLIN, Ireland — Perrigo Co. plc plans to sell its U.S. vitamins, minerals and supplements (VMS) business to International Vitamin Corp. (IVC). Financial terms of the deal weren’t disclosed. Perrigo said Monday that the company had been looking to sell off its VMS business and that it expects the transaction to close by early August,

Perrigo, Allergan ship generic of Mucinex DM

Perrigo, Allergan ship generic of Mucinex DM

DUBLIN, Ireland — Perrigo Co. and Allergan plc have rolled out guaifenesin 1,200-mg and dextromethorphan HBr 60-mg extended-release tablets, a combination expectorant and cough suppressant. The companies said Tuesday that the product marks the first over-the-counter store-brand equivalent to Mucinex DM 1,200-mg ER tablets from Reckitt Benckiser (RB) for retail and wholesale customers. First shipments

Valeant names Perrigo’s Papa as chairman, CEO

Valeant names Perrigo’s Papa as chairman, CEO

NEW YORK — Joseph Papa has resigned as chairman and chief executive officer of Perrigo Co. plc to join Valeant Pharmaceuticals International Inc. as chairman and CEO. Valeant said Monday that Papa, 60, is slated to start at the company by early May. Papa will succeed J. Michael Pearson, who is expected to remain as

Perrigo rolls out store-brand Glucerna shake

Perrigo rolls out store-brand Glucerna shake

DUBLIN, Ireland — Perrigo Co. plc has begun shipping a store-brand version of Abbott’s Glucerna aseptic nutritional shake for adults with diabetes. Perrigo said Tuesday that its product represents a first-to-market launch of an over-the-counter, private-brand equivalent to Glucerna. The company said its product is packaged and marketed as a store brand or retailer “own

CHPA announces new officers, board members

CHPA announces new officers, board members

WASHINGTON — The Consumer Healthcare Products Association (CHPA) has elected officers and members to its board of directors. CHPA said Wednesday that Patrick Lockwood-Taylor, vice president of Personal Health Care North America and Digestive Wellness Design for Procter & Gamble Co., will continue to serve as chairman. Jeffrey Needham, executive vice president and general manager

Mylan to acquire Meda in $9.9 billion deal

Mylan to acquire Meda in $9.9 billion deal

HERTFORDSHIRE, England — Mylan N.V. plans to acquire Sweden-based pharmaceuticals manufacturer Meda AB in a deal valued at $9.9 billion, including debt. Mylan said late Wednesday that the offer to Meda includes cash and Mylan shares, with the equity portion valued at $7.2 billion. Executives from both companies noted that a Mylan-Meda combination would create

Perrigo closes Retin-A acquisition

Perrigo closes Retin-A acquisition

DUBLIN, Ireland — Perrigo Co. plc has completed its acquisition of a portfolio of generic dosage forms and strengths of acne topical treatment Retin-A from Matawan Pharmaceuticals LLC. Financial terms of deal, announced in mid-December, weren’t disclosed. Perrigo was the authorized generic distributor of these Retin-A (tretinoin) products from 2005 to 2013 before the agreement

Perrigo recalls store-brand children’s guaifenesin liquid

Perrigo recalls store-brand children’s guaifenesin liquid

DUBLIN, Ireland — Perrigo Co. plc has voluntarily recalled some batches of its children’s guaifenesin liquid in the United States following a recent recall of certain dosing cups by its supplier. Perrigo said Monday that the recall, to the retail level, involves two batches of its children’s guaifenesin grape liquid (100 mg/5 ml), an expectorant,

Allergan, Perrigo launch store-brand Mucinex D

Allergan, Perrigo launch store-brand Mucinex D

DUBLIN, Ireland — Allergan plc and Perrigo Co. plc have launched combination guaifenesin 600-mg and pseudoephedrine HCl 60-mg extended-release tablets to retail and wholesale customers. Allergan and Perrigo said Monday that the initial shipments of the new store-brand product, which began in December, mark a first-to-market achievement for the companies. “This first-to-market launch illustrates the

Mylan takes hostile bid to Perrigo stockholders

Mylan takes hostile bid to Perrigo stockholders

HERTFORDSHIRE, England — As promised, Mylan N.V. has proceeded to make formal bid to acquire Perrigo Co. plc in a deal valued at approximately $27 billion. Mylan said Monday that under the offer, Perrigo shareholders would receive $75 in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share. That would translate to a